What Is the Strength of Evidence for Heart Failure Disease-Management Programs?

Journal of the American College of Cardiology

Volumn 54, Issue 5, 2009, Pages 397-401

  Clark, Alexander M ^a   Savard, Lori A ^a   Thompson, David R ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

CHF; chronic; disease management; health promotion; self care

Indexed keywords

CLINICAL RESEARCH; EVIDENCE BASED MEDICINE; HEART FAILURE; HUMAN; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

DISEASE MANAGEMENT; EPIDEMIOLOGIC RESEARCH DESIGN; EVIDENCE-BASED MEDICINE; HEALTH PROMOTION; HEART FAILURE; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PROGRAM EVALUATION;

EID: 67650535210     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.04.051     Document Type: Review

References (66)

1. Jaarsma T., van der Wal M., Lesman-Leegte I., et al. Effect of moderate or intensive disease management program on outcome in patients with heart failure coordinating study evaluating outcomes of advising and counseling in heart failure (COACH). Arch Intern Med 168 (2008) 316-324
2. Nucifora G., Albanese M., De Biaggio P., et al. Lack of improvement of clinical outcomes by a low-cost, hospital-based heart failure management programme. J Cardiovasc Med 7 (2006) 614-622
3. Smith B., Forkner E.Z., Krasuski R., et al. Disease management produces limited quality-of-life improvements in patients with congestive heart failure: evidence from a randomized trial in community-dwelling patients. B. Am J Manage Care 11 (2005) 701-703
4. Nguyen V., Ducharme A., White M., et al. Lack of long-term benefits of a 6-month heart failure disease management program. J Card Fail 13 (2006) 287-293
5. Holland R., Brooksby I., Lenaghan E., et al. Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial. BMJ 334 (2007) 1098
6. Ledwidge M., Ryan E., O'Loughlin C., et al. Heart failure care in a hospital unit: a comparison of standard 3-month and extended 6-month programs. Eur J Heart Fail 16 (2005) 385-391
7. Boutron I., Moher M., Altman D.G., Schulz K.F., Ravaud P., and CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 148 (2008) 295-309
8. Medical Research Council. Developing and Evaluating Complex Interventions (2008), MRC, London
9. Craig P., Dieppe P., MacItyre S., Mitchie S., Nazareth I., and Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council Guidance. BMJ 337 (2008) 979-983
10. Campbell N., Murray E., Darbyshire J., et al. Designing and evaluating complex interventions to improve health care. BMJ 334 (2007) 455-459
11. Guyatt G., Rennie D., Meade M., and Cook D. User's guide to the medical literature (2008), American Medical Association, New York, NY
12. Pawson R. Evidence-Based Policy: A Realist Perspective (2006), Sage, London
13. Singh D. How Can Chronic Disease Managament Programmes Operate Across Care Settings and Providers? (2008), World Health Organization, Cophenhagen
14. Shiell A., Hawe P., and Gold L. Complex interventions or complex systems?. Implications for health economic evaluation. BMJ 336 (2008) 1281-1283
15. Krumholz H., Currie P., Riegel B., et al. A taxonomy for disease management: a scientific statement from the American Heart Assocaition Disease Management Taxononmy Writing Group. Circulation 114 (2006) 1432-1445
16. Glasgow R.E., and Emmons K.M. How can we increase the translation of research into practice: types of evidence needed. Ann Rev Publ Health 28 (2007) 413-433
17. Guyatt G., Straus S., Meade M.O., et al. Therapy (randomized trials). In: Guyatt G., Rennie D., Meade M.O., and Cook D.J. (Eds). Users' Guides to the Medical Literature: A Manual for Evidence based Clinical Practice. 2nd edition (2008), McGraw-Hill Professional, New York, NY 67-86
18. Nallamothu B.K., and Hayward R.A. Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation 118 (2008) 1294-1303
19. Clark A.M., and Thompson D.R. The future of heart failure disease management programs. Lancet 372 (2008) 784-786
20. Gohler A., Januzzi J., Worrell S.S., et al. A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure. J Card Fail 12 (2006) 554-567
21. Herbert P.L., and Sisk J.E. Challenges facing nurse-led disease management for heart failure. Disease Manage Health Outcomes 16 (2008) 1-6
22. Taylor S., Bestall J., Cotter S., et al. Clinical service organization for heart failure. Cochrane Database of Syst Rev 2 (2005) CD002752
23. Ekman I., and Swedberg K. Home-based management of patients with chronic heart failure-focus on content not just form!. Eur Heart J 23 (2002) 1323-1325
24. Pawson R., and Tilley N. Realistic Evaluation (1997), Sage, London
25. Roccaforte R., Demers C., Baldassarrre F., Teo K., and Yusuf S. Effectiveness of comprehensive disease management programmes in improving outcomes in heart failure patients. A meta-analysis. Eur J Heart Fail 7 (2005) 1133-1144
26. Koshman S., Charrois T., Simpson S., McAlister F., and Tsuyuki R. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med 168 (2008) 687-694
27. Yu D.S.F., Thompson D.R., and Lee D.T.F. Disease management programmes for older people with heart failure: crucial characteristics which improve post-discharge outcomes. Eur Heart J (2006) 596-612
28. Chin M., Wang J., and Zhang J. Utilization and dosing of angio-tensin-converting enzymes inhibitors for heart failure. Effect of physician specialty and patient characteristics. J Gen Intern Med 12 (1997) 563-566
29. Remme W. Filling the gap between guidelines and clinical practice in heart failure treatment: still a far cry from reality. Eur J Heart Fail 9 (2007) 1143-1145
30. Groote P.I.R., Assyag P., Clerson P., Ducardonnet A., Galinier M., et al. Is the gap between guidelines and clinical practice in heart failure treatment being filled?. Insights from the IMPACT RECO survey. Eur J Heart Fail 9 (2007) 1205-1211
31. Patel J., and Fotis M. Comparison of treatment of patients with heart failure by cardiologists versus noncardiologists. Am J Health-System Pharmacy 62 (2005) 168-172
32. Rutten F., Gribbee D., and Hoes A. Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day. Eur J Heart Fail 5 (2003) 337-344
33. Inglis S.C., Pearson S., Treen S., Gallasch T., Horowitz J.D., and Stewart S. Extending the horizon in chronic heart failure: effects of multidisciplinary, home-based intervention relative to usual care. Circulation 114 (2006) 2466-2473
34. Del Sindaco D., Pulignano G., Minardi G., et al. Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure. J Cardiovasc Med 8 (2007) 324-329
35. Murray M., Young J., Hoke S., et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med 146 (2007) 714-725
36. Whellan D.J., Hasselblad V., Peterson E., O'Conner C., and Schulman K. Metaanalysis and review of heart failure disease management randomized controlled clinical trials. Am Heart J 149 (2005) 722-729
37. McAlister F.A., Stewart S., Ferrua S., and McMurray J.J. Multi-disciplinary strategies for the management of heart failure patients at high risk of admission: a systematic review of randomized trials. J Am Coll Cardiol 44 (2004) 810-819
38. Gonseth J., Guallar-Castillion P., Banegas J., and Rodriguez-Artelajo F. The effectiveness of disease management programmes in reducing hospital re-admissoin in older patients with heart failure: a systematic review of published papers. Eur Heart J 25 (2004) 1570-1595
39. Gwadry-Sridhar F.H., Flintoft V., Lee D.S., Lee H., and Guyatt G.H. A systematic review and meta-analysis of studies comparing readmission rates and mortality rates in patients with heart failure. Arch Intern Med 164 (2004) 2315-2320
40. McAlister F.A., Lawson F.M.E., Teo K.K., and Armstrong P.W. A systematic review of randomized trials of disease management programs in heart failure. Am J Med 110 (2001) 378-384
41. Holland R., Battersby J., Harvey I., Lenaghan E., Smith J., and Hay L. Systematic review of multidisciplinary interventions in heart failure. Heart 91 (2005) 899-906
42. Clark R., Inglis S., McAlister F., Cleland J., and Stewart S. Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. BMJ 334 (2007) 942
43. Jovicic A., Holroyd-Leduc J.M., and Straus S.E. Effects of self-management intervention on health outcomes of patients with heart failure: a systematic review of randomized controlled trials. BMC Cardiovasc Disord 6 (2006) 43
44. Kim Y., and Soeken K.L. A meta-analysis of the effect of hospital-based case management on hospital length of stay and readmission. Nurs Res 54 (2005) 255-264
45. Roccaforte R., Demers C., Baldassarre F., Teo K.K., and Yusuf S. Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients: a meta-analysis. Eur J Heart Fail 7 (2005) 1133-1144
46. Phillips C.O., Wright S.M., Kern D.E., Singa R.M., Shepperd S., and Rubin H.R. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. JAMA 291 (2004) 1358-1367
47. Brok J., Thorlund K., Wetterslev J., and Gluud C. Apparently conclusive meta-analyses may be inconclusive-trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. Int J Epidemiol 38 (2009) 287-298
48. Gustafsson F., and Arnold J. Heart failure clinics and outpatient management: review of the evidence and call for quality assurance. Eur Heart J 25 (2004) 1596-1604
49. Detsky A.S., Naylor C.D., O'Rourke K., McGeer A.J., and L'Abbé K.A. Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol 45 (1992) 255-265
50. Tu K., Gong Y., Austin P., Jaakimanian L., Tu J., and Canadian Cardiovascular Outcomes Research Team. An overview of the types of physicians treating acute cardiac conditions in Canada. Can J Cardiol 20 (2004) 282-291
51. Roger V., Weston S., Redfield M., et al. Trends in heart failure incidence and survival in a community-based population. JAMA 292 (2004) 344-350
52. Hahn S., Williamson P.R., Hutton J.L., Garner P., and Flynn E.V. Assessing the potential for bias in meta-analysis due to selective reporting of subgroup analyses within studies. Stat Med 19 (2000) 3325-3336
53. Xu H., Platt R.W., Luo Z.C., Wei S., and Fraser W.D. Exploring heterogeneity in meta-analyses: needs, resources and challenges. Paediatr Perinat Epidemiol 22 (2008) 18-28
54. Lau J., Ioannidis J.P.A., and Schmid C.H. Summing up the evidence: one answer is not always enough. Lancet 351 (1998) 123-127
55. Ioannidis J.P.A., Patsopoulos N.A., and Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ 335 (2007) 914-916
56. Higgins J.P.T. Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol 37 (2008) 1158-1160
57. Higgins J., Thompson S., Deeks J., and Altman D. Measuring inconsistency in meta-analysis. BMJ 327 (2003) 557-560
58. Fletcher J. What is heterogeneity and is it important?. BMJ 334 (2007) 94-96
59. Phillips C.O., Singa R.M., Rubin H.R., and Jaarsma T. Complexity of program and clinical outcomes of heart failure disease management incorporating specialist nurse-led heart failure clinics. A meta-regression analysis. Eur J Heart Fail 7 (2005) 333-341
60. Egger M., Davey Smith D.G., and O'Rourke K. Rationale, potentials, and promise of systematic revew. In: Egger M., Davey Smith D.G., and Altman D.G. (Eds). Systematic Reviews in Health Care: Meta Analysis in Context (2001), BMJ Books, London 3-19
61. Feinstein A.R. Meta-analysis: Statistical alchemy for the 21st century. J Clin Epidemiol 48 (1995) 71-79
62. Bagshaw S., McAlister F.A., Manns B., and Ghali W. Acetylcysteine in the prevention of constrast induced nephropathy. Ann Intern Med 166 (2006) 161-166
63. Glasziou P., Meats E., Heneghan C., and Shepperd S. What is missing from descriptions of treatment in trials and reviews?. BMJ 336 (2008) 1472-1474
64. Schulze R., Holling H., Grobmann H., Jutting A., and Brocke M. Differences in the results of two meta-analytical approaches. In: Schulze R., Holling H., and Bohning D. (Eds). Meta-Analysis: New Developments and Applications in Medical and Social Sciences (2003), Hogrefe & Huber, Cambridge, MA 21-40
65. Koch A., and Rohmel J. Meta-analysis of randomized clinical trials in the evaluation of medical treatments: a partly regularatory perspective. In: Schulze R., Holling H., and Bohning D. (Eds). Meta-Analysis: New Developments and Application in Medical and Social Sciences (2003), Hogrefe & Huber, Cambridge, MA 99-112
66. Mutt G.E. Will it work in Munster?. Meta-analysis and the empirical generalization of causal relationships. In: Schulze R., Holling H., and Bohning D. (Eds). Meta-Analysis: New Developments and Application in Medical and Social Sciences (2003), Hogrefe & Huber, Cambridge, MA 113-140